Biomolecules & Therapeutics

The Korean Society of Applied Pharmacology (한국응용약물학회)
권호 표지
DOI QR코드

DOI QR Code

Ethyl Docosahexaenoate and Its Acidic Form Increase Bone Formation by Induction of Osteoblast Differentiation and Inhibition of Osteoclastogenesis

  • Choi, Bo-Yun (Department of Dental Pharmacology, School of Dentistry and Institute of Oral Bioscience, Brain Korea 21 Project, Chonbuk National University) ;
  • Eun, Jae-Soon (College of Pharmacy, Woosuk University) ;
  • Nepal, Manoj (Department of Dental Pharmacology, School of Dentistry and Institute of Oral Bioscience, Brain Korea 21 Project, Chonbuk National University) ;
  • Lee, Mi-Kyung (College of Pharmacy, Woosuk University) ;
  • Bae, Tae-Sung (Department of Dental Biomaterials, School of Dentistry, Chonbuk National University) ;
  • Kim, Byung-Il (Department of Materials Science and Metallurgical Engineering, Sunchon National University) ;
  • Soh, Yun-Jo (Department of Dental Pharmacology, School of Dentistry and Institute of Oral Bioscience, Brain Korea 21 Project, Chonbuk National University)
  • Received : 2010.11.25
  • Accepted : 2011.01.07
  • Published : 2011.01.31
Download PDF
⟨ Previous Next ⟩

Abstract

Bone remodeling is a dynamic process involving a constant balance between osteoclast-induced bone resorption and osteoblast-induced bone formation. Osteoclasts play a crucial homeostatic role in skeletal modeling and remodeling, and destroy bone in many pathological conditions. Previously, we reported that the hexane soluble fraction of Ficus carica inhibited osteoclast differentiation. Poly unsaturated fatty acids, such as ethyl docosahexaenoate (E-DHA), docosahexaenoic acid (DHA), cis-11,14-eicosadienoic acid (EDA) and eicosapentaenoic acid (EPA), were identified from the hexane soluble fraction of Ficus carica. Among them, E-DHA most potently inhibited osteoclastogenesis in RAW264.7 cells. E-DHA reduced the activities of JNK and NF-$\kappa}B$. E-DHA suppressed the expression of c-Fos and nuclear factor of activated T cells c1 (NFATc1). Interestingly, DHA increased the activity of alkaline phosphatase and expression of bone morphogenetic protein 2 (BMP2) more than E-DHA in MC3T3-E1 cells, suggesting that DHA may induce osteoblast differentiation. The data suggests that a combination of E-DHA and DHA has potential use in the treatment of diseases involving abnormal bone lysis, such as osteoporosis, rheumatoid arthritis and periodontal bone erosion.

Keywords

References

  1. Calder, P. C. and Zurier, R. B. (2001) Poryunsaturated fatty acids andrheumatoid arthritis. Curr. Opin. Clin. Nutr. Metab. Care. 4, 115-121. https://doi.org/10.1097/00075197-200103000-00006
  2. Choi, H. J., Park, Y. R., Nepal, M., Choi, B. Y., Cho, N. P., Choi, S. H.,Heo, S. R., Kim, H. S., Yang, M. S. and Soh, Y. (2010) Inhibition ofosteoclastogenic differentiation by Ikarisoside A in RAW 264.7 cellsvia JNK and NF-kappaB signaling pathways. Eur. J. Pharmacol.636, 28-35. https://doi.org/10.1016/j.ejphar.2010.03.023
  3. Hudert, C. A., Weylandt, K. H., Lu, Y., Wang, J., Hong, S., Dignass,A., Serhan, C. N. and Kang J. X. (2006) Transgenic mice rich inendogenous omega-3 fatty acids are protected from colitis. Proc.Natl. Acad. Sci. USA. 103, 11276-11281. https://doi.org/10.1073/pnas.0601280103
  4. Kobayashi, N., Kadono, Y., Naito, A., Matsumoto, K., Yamamoto, T.,Tanaka, S. and Inoue, J. (2001) Segregation of TRAF6-mediatedsignaling pathways clarifies its role in osteoclastogenesis. EMBOJ. 20, 1271-1280. https://doi.org/10.1093/emboj/20.6.1271
  5. Lee, S. E., Woo, K. M., Kim, S. Y., Kim, H. M., Kwack, K., Lee, Z. H.and Kim, H. H. (2002) The phosphatidylinositol 3-kinase, p38, andextracellular signal-regulated kinase pathways are involved in osteoclastdifferentiation. Bone 30, 71-77.
  6. Lee, W. T. (1996) Coloured standard illustrations of Korean plants. pp. 642. Academy Press, Seoul.
  7. Liu, C., Walter, T. S., Huang, P., Zhang, S., Zhu, X., Wu, Y., Wedderburn,L. R., Tang, P., Owens, R. J., Stuart, D. I., Ren, J. and Gao, B.(2010) Structural and functional insights of RANKL-RANK interactionand signaling. J. Immunol. 184, 6910-6919. https://doi.org/10.4049/jimmunol.0904033
  8. Luo, J. L., Kamata, H. and Karin, M. (2005) IKK/NF-kappaB signaling:balancing life and death--a new approach to cancer therapy. J.Clin. Invest. 115, 2625-2632. https://doi.org/10.1172/JCI26322
  9. Meydani, S. N., Endres, S., Woods, M. M., Goldin, B. R., Soo, C.,Morrill-Labrode, A., Dinarello, C. A. and Gorbach, S. L. (1991) Oral(n-3) fatty acid supplementation suppresses cytokine productionand lymphocyte proliferation: comparison between young and olderwomen. J. Nutr. 121, 547-555.
  10. Mori, T. A. and Beilin, L. J. (2001) Long-chain omega 3 fatty acid bloodlipids and cardiovascular risk reduction. Curr. Opin. Lipidol. 12, 11-17. https://doi.org/10.1097/00041433-200102000-00003
  11. Mukherjee, A., Wilson, E. M. and Rotwein, P. (2010) Selective signalingby Akt2 promotes bone morphogenetic protein2-mediated osteoblastdifferentiation. Mol. Cell. Biol. 30, 1018-1027. https://doi.org/10.1128/MCB.01401-09
  12. Otsuka, E., Notoya, M. and Hagiwara, H. (2003) Treatment of myoblasticC2C12 cells with BMP-2 stimulates vitamin D-induced formationof osteoclasts. Calcif. Tissue Int. 73, 72-77. https://doi.org/10.1007/s00223-002-1071-0
  13. Park, C. K., Lee, Y., Chang, E. J., Lee, M. H., Yoon, J. H., Ryu, J. H.and Kim, H. H. (2008) Bavachalcone inhibits osteoclast differentiationthrough suppression of NFATc1 induction by RANKL. Biochem.Pharmacol. 75, 2175-2182. https://doi.org/10.1016/j.bcp.2008.03.007
  14. Park, Y. R., Eun, J. S., Choi, H. J., Nepal, M., Kim, D. K., Seo, S. Y., Li,R., Moon, W. S., Cho, N. P., Cho, S. D., Bae, T. S., Kim, B. I. andSoh, Y. (2009) Hexane-soluble fraction of the common fig, ficuscarica, inhibits osteoclast differentiation in murine bone marrowderivedmacrophages and RAW 264.7 cells. Korean J. Physiol.Pharmacol. 13, 417-424. https://doi.org/10.4196/kjpp.2009.13.6.417
  15. Poulsen, R. C., Firth, E. C., Rigers, C. W., Moughan, P. J. and Kruger,M. C. (2007) Specific effects of gamma-linolenic, eicosapentaenoic,and docosahexaenoic ethyl esters on bone post-ovariectomy inrats. Calcif. Tissue Int. 81, 459-471. https://doi.org/10.1007/s00223-007-9080-7
  16. Raggatt, L. J. and Partridge, N. C. (2010) Cellular and molecularmechanisms of bone remodeling. J. Biol. Chem. 285(33), 25103-25108. https://doi.org/10.1074/jbc.R109.041087
  17. Rahman, M. M., Bhattacharya, A. and Fernandes, G. (2008) Docosahexaenoicacid is more potent inhibitor of osteoclast differentiation in RAW 264.7 cells than eicosapentaenoic acid. J. Cell. Physiol. 214, 201-209 https://doi.org/10.1002/jcp.21188
  18. Reddy, S. V., Hundley, J. E., Windle, J. J., Alcantara, O., Linn, R.,Leach, R. J., Boldt, D. H. and Roodman, G. D. (1995) Characterizationof the mouse tartrate-resistant acid phosphatase (TRAP)gene promoter. J. Bone Miner. Res. 10, 601-606.
  19. Simopoulos, A. P., Kifer, R. R. and Wykes, A. A. (1991) Omega 3fatty acid: Research advance and support in the fi eld since June1985(worldwide). World Rev Nutr Diet. 66, 51-71.
  20. Sun, D., Krishnan, A., Zaman K., Lawrence, R., Bhattacharya, A. andFernandes, G. (2003) Dietary n-3 fatty acids decrease osteoclastogenesisand loss of bone mass in ovariectomizes mice. J. BoneMiner Res. 18, 1206-1216. https://doi.org/10.1359/jbmr.2003.18.7.1206
  21. Tachi, K., Takami, M., Sato, H., Mochizuki, A., Zhao, B., Miyamoto, Y.,Tsukasaki, H., Inoue, T., Shintani, S., Koike, T., Honda, Y., Suzuki,O., Baba, K. and Kamijo, R. (2010a) Enhancement of bone morphogeneticprotein-2-inhanced ectopic bone formation by transforminggrowth $factor-{\beta}1$. Tissue Eng. Part A. Epub ahead of print.
  22. Tachi, K., Takami, M., Zhao, B., Mochizuki, A., Miyamoto, Y., Inoue, T.,Baba, K. and Kamijo, R. (2010b) Bone morphogenetic protein 2enhances mouse osteoclast differentiation via increased levels ofreceptor activator of $NF-{\kappa}B$ ligand expression in osteocblast. Cell Tissue Res. 342, 213-220. https://doi.org/10.1007/s00441-010-1052-y
  23. Takayanagi, H., Kim, S., Koga, T., Nishina, H., Isshiki, M., Yoshida, H.,Saiura, A., Isobe, M., Yokochi, T., Inoue, J., Wagner, E. F., Mak, T.W., Kodama, T. and Taniguchi, T. (2002) Induction and activation ofthe transcription factor NFATc1 (NFAT2) integrate RANKL signalingin terminal differentiation of osteoclasts. Dev. Cell 3, 889-901. https://doi.org/10.1016/S1534-5807(02)00369-6
  24. Theill, L. E., Boyle, W. J. and Penninger, J. M. (2002) RANK-L andRANK: T cells, bone loss, and mammalian evolution. Annu. Rev.Immunol. 20, 795-823. https://doi.org/10.1146/annurev.immunol.20.100301.064753
  25. Yaqoob, P. and Calder, P. (1995) Effects of dietary lipid manipulationupon inflammatory mediator production by murine macrophages.Cell Immunol. 163, 120-128. https://doi.org/10.1006/cimm.1995.1106
  26. Yoshida, H., Hayashi, S., Kunisada, T., Ogawa, M., Nishikawa, S.,Okamura, H., Sudo, T., Shultz, L. D. and Nishikawa, S. (1990) Themurine mutation osteopetrosis is in the coding region of the macrophagecolony stimulating factor gene. Nature. 345, 442-444. https://doi.org/10.1038/345442a0
  27. Zhao, Q., Shao, J., Chen, W. and Li, Y. P. (2007) Osteoclast differentiationand gene regulation. Front Biosci. 12, 2519-2529 https://doi.org/10.2741/2252

Cited by

  1. Omega‐3 fatty acids in pathological calcification and bone health vol.44, pp.8, 2011, https://doi.org/10.1111/jfbc.13333